Cooper Companies (NASDAQ:COO) Issues Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Key Points

• Earnings beat: Cooper Companies reported EPS of $1.10 vs. a $1.03 consensus (beat by $0.07) with revenue of $1.02B in line, and updated Q2 2026 guidance to a $4.580–$4.660 EPS range.
• Stock reaction and valuation: Shares fell to $80.20 on the day despite the beat, trading about 2.3M shares; market cap is $15.65B with a P/E of 42.66 and a 1-year range of $61.78–$91.59.
• Insider buying: CEO Albert G. White III purchased 10,000 shares at roughly $80.80 and insiders bought 16,014 shares over the past 90 days, suggesting management confidence.

Cooper Companies (NASDAQ:COO - Get Free Report) posted its quarterly earnings data on Thursday. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.03 by $0.07, FiscalAI reports. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%. Cooper Companies updated its Q2 2026 guidance to 4.580-4.660 EPS.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded down $1.78 during trading on Thursday, hitting $80.20. 2,295,346 shares of the company's stock traded hands, compared to its average volume of 1,984,194. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $91.59. The business has a 50-day simple moving average of $82.28 and a 200-day simple moving average of $75.92. The stock has a market capitalization of $15.65 billion, a P/E ratio of 42.66, a PEG ratio of 2.38 and a beta of 1.02. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on COO shares. Needham & Company LLC decreased their price target on shares of Cooper Companies from $100.00 to $99.00 and set a "buy" rating for the company in a research note on Tuesday, February 3rd. JPMorgan Chase & Co. raised their target price on shares of Cooper Companies from $66.00 to $78.00 and gave the company a "neutral" rating in a research note on Friday, December 5th. Rothschild & Co Redburn downgraded Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 price target on the stock. in a research note on Wednesday. The Goldman Sachs Group reaffirmed a "sell" rating and set a $73.00 price objective on shares of Cooper Companies in a research report on Friday, January 9th. Finally, Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the stock a "buy" rating in a report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $90.36.

Insider Activity

In related news, CEO Albert G. White III purchased 10,000 shares of Cooper Companies stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the completion of the purchase, the chief executive officer directly owned 236,151 shares of the company's stock, valued at $19,081,000.80. The trade was a 4.42% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Holly R. Sheffield acquired 1,230 shares of the firm's stock in a transaction dated Tuesday, December 16th. The shares were bought at an average cost of $80.75 per share, with a total value of $99,322.50. Following the completion of the acquisition, the insider directly owned 39,052 shares of the company's stock, valued at $3,153,449. The trade was a 3.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have bought 16,014 shares of company stock worth $1,304,416. 2.08% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently modified their holdings of the company. Captrust Financial Advisors raised its holdings in Cooper Companies by 10.0% in the 2nd quarter. Captrust Financial Advisors now owns 3,500 shares of the medical device company's stock worth $249,000 after purchasing an additional 317 shares during the period. Snowden Capital Advisors LLC increased its position in Cooper Companies by 10.0% in the second quarter. Snowden Capital Advisors LLC now owns 4,088 shares of the medical device company's stock worth $291,000 after buying an additional 373 shares in the last quarter. Cresset Asset Management LLC bought a new position in shares of Cooper Companies in the second quarter worth about $291,000. Brown Brothers Harriman & Co. raised its stake in shares of Cooper Companies by 88.4% in the fourth quarter. Brown Brothers Harriman & Co. now owns 1,984 shares of the medical device company's stock worth $163,000 after buying an additional 931 shares during the period. Finally, Parallel Advisors LLC lifted its position in shares of Cooper Companies by 72.8% during the 4th quarter. Parallel Advisors LLC now owns 1,583 shares of the medical device company's stock valued at $130,000 after buying an additional 667 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.